Literature DB >> 15211238

[Diffuse idiopathic interstitial pneumonias. International multidisciplinary consensus classification by the American Thoracic Society and the European Respiratory Society, principal clinico-pathological entities, and diagnosis].

V Cottin1, F Capron, P Grenier, J-F Cordier.   

Abstract

INTRODUCTION: The classification of the idiopathic interstitial pneumonias includes seven clinico-pathologic entities. The diagnosis is based on a multidisciplinary approach, integrating the clinical evaluation, the high-resolution computerised tomography, and the pathological pattern. STATE OF THE ART: A definitive diagnosis of idiopathic pulmonary fibrosis relies on the association of a suggestive clinico-radiological profile and a pathological pattern of usual interstitial pneumonia. Nonspecific interstitial pneumonia is a recently described clinico-pathologic entity, with a better prognosis than that of idiopathic pulmonary fibrosis. Cryptogenic organising pneumonia has been included in the group of idiopathic interstitial pneumonias because of its idiopathic and multifocal characteristics, although it does not predominate in the lung interstitium. Desquamative interstitial pneumonia and respiratory bronchiolitis with interstitial lung disease are rare entities with predominance in young smoking adults. Lymphoid interstitial pneumonia, usually encountered in the context of Sjögren's syndrome, is very rare in its idiopathic form. Acute interstitial pneumonia is responsible for idiopathic acute respiratory distress syndrome. PERSPECTIVES: The current classification of idiopathic interstitial pneumonias better defines the diagnostic criterias of each clinico-pathologic entity, and is expected to facilitate clinical research.
CONCLUSIONS: This classification has clinical implications, with prognostic and therapeutic significance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15211238     DOI: 10.1016/s0761-8425(04)71288-7

Source DB:  PubMed          Journal:  Rev Mal Respir        ISSN: 0761-8425            Impact factor:   0.622


  6 in total

Review 1.  Oxidant/Antioxidant Disequilibrium in Idiopathic Pulmonary Fibrosis Pathogenesis.

Authors:  Paolo Cameli; Alfonso Carleo; Laura Bergantini; Claudia Landi; Antje Prasse; Elena Bargagli
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

2.  Classification and Pathological Diagnosis of Idiopathic Interstitial Pneumonia.

Authors:  Zhihua Chen; Wenqiang Huang; Yibo Song
Journal:  Comput Intell Neurosci       Date:  2022-05-31

Review 3.  Yiqi Yangyin Huoxue Method in Treating IdiopathicPulmonary Fibrosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Min Zhou; Chao Ye; Qijun Liang; Qiulan Pei; Fan Xu; Hang Wen
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-03       Impact factor: 2.629

4.  Heterologous Matrix Metalloproteinase Gene Promoter Activity Allows In Vivo Real-time Imaging of Bleomycin-Induced Lung Fibrosis in Transiently Transgenized Mice.

Authors:  Fabio Franco Stellari; Francesca Ruscitti; Daniela Pompilio; Francesca Ravanetti; Giulia Tebaldi; Francesca Macchi; Andrea Elizabeth Verna; Gino Villetti; Gaetano Donofrio
Journal:  Front Immunol       Date:  2017-03-01       Impact factor: 7.561

Review 5.  The safety of biologic therapies in RA-associated interstitial lung disease.

Authors:  Meghna Jani; Nik Hirani; Eric L Matteson; William G Dixon
Journal:  Nat Rev Rheumatol       Date:  2013-12-24       Impact factor: 20.543

Review 6.  Genomics of Human Fibrotic Diseases: Disordered Wound Healing Response.

Authors:  Rivka C Stone; Vivien Chen; Jamie Burgess; Sukhmani Pannu; Marjana Tomic-Canic
Journal:  Int J Mol Sci       Date:  2020-11-14       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.